(ANSA) - Rome, April 30 - Oxford University's Jenner
Institute and drug multinational AstraZeneca have reached a deal
to hasten the production of a coronavirus vaccine that the
multinational said has already been shown to be "safe and well
tolerated", the Italian partner in the project, the IRBM firm in
Pomezia south of Rome, said on Thursday.
AstraZeneca said the vaccine had already been safely tested
on 320 patients and it was hoping to move forward with global
mass production as soon as possible.
IRBM President Pietro Di Lorenzo told ANSA the first stock of
the vaccine would probably be available in December if the
outcome of tests is positive, and priority would be given to
"fragile groups".
Oxford uni-AstraZeneca vaccine deal
First stock likely in December says Italian partner IRBM